A new flu strain is sweeping across Europe, stretching healthcare systems and reigniting concerns about the season. The World Health Organization (WHO) reports a sharp rise in flu activity, driven by a recently dominant virus variant, and notes that many countries are feeling the strain.
According to data collected in Europe, at least 27 of the 38 WHO-designated European region countries are experiencing high or very high influenza activity. In six countries—including Ireland, Serbia, Slovenia, and the United Kingdom—more than half of people with flu-like symptoms test positive, underscoring a widespread surge. The season has started roughly a month earlier than in recent years, prompting public health guidance to reduce transmission: get vaccinated, stay home when sick, and wear a mask in public if you have respiratory symptoms.
The surge is chiefly attributed to a new seasonal flu variant—A(H3N2) sub-clade K—that appears to account for up to about 90% of confirmed flu cases across Europe. However, the WHO indicates there is no evidence that this variant is causing more severe disease than typical. Hans Henri Kluge, the WHO regional director for Europe, noted that flu evolves each winter, yet this year’s slightly different pattern demonstrates how even small genetic changes can place heavy demands on health systems.
Misinformation is highlighted as a risk in parallel with the spread. Kluge urges people to rely on credible information from trusted sources such as national health agencies and the WHO, stressing that in a tough flu season, sound, evidence-based guidance can save lives.
Early UK data suggest that the flu vaccine reduces the risk of severe illness from the A(H3N2) strain, though it may not always prevent infection. Vaccination remains the single most important preventive step, particularly for those at higher risk—including older adults, individuals with chronic conditions, pregnant people, and children. Health workers are also prioritized to safeguard their health and patient safety.
As with past seasons, school-age children are central to community transmission, while older adults (65 and up) represent the majority of severe cases requiring hospitalization.
Kluge anticipates the flu season peaking in late December or early January. He emphasizes that while the current season is serious, it does not constitute the same global emergency witnessed during the COVID-19 pandemic. Health authorities note that modern systems have substantial influenza-management experience, vaccines are updated annually, and a clear set of protective measures remains in place.
Preliminary reports from the United Kingdom align with these concerns, and other European nations have reported early season activity. Germany’s Robert Koch Institute indicates the season has begun there a few weeks earlier than usual, while France reports a marked uptick in flu activity across age groups and rising emergency-department visits. Spain already shows infection levels above last winter’s peak, with hospitalizations increasing, and Romania and Hungary are also experiencing notable surges.
Overall, the picture is one of an early, robust flu season driven by a dominant A(H3N2) sub-clade, prompting renewed emphasis on vaccination, protective behaviors, and vigilant public health communication. If you’re unsure about your risk or vaccination timing, consult your local health authority for guidance and trusted resources. In the comments, what are your thoughts on how communities can best balance caution with normal activities during flu season?
